PAR 1.96% 26.0¢ paradigm biopharmaceuticals limited..

I cannot be certain, but this may be from the expectation we...

  1. 896 Posts.
    lightbulb Created with Sketch. 277
    I cannot be certain, but this may be from the expectation we will obtain TGA provisional approval later this year, resulting in sales, but followed by greater Phase 3 trial expenses in 2021.

    Perhaps Mozzarc, who knows the timetable much better than I, could comment on whether my theory is sound or not.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.